Departamento de Química, Universidad de Guanajuato, Cerro de la Venada s/n, Guanajuato, Gto, C.P. 36040, Mexico.
Contrast Media Mol Imaging. 2010 May-Jun;5(3):121-5. doi: 10.1002/cmmi.371.
The synthesis of new DOTA tetraamide (DOTAMR(4)) compounds is of great interest given their application in the formation of Ln(III) complexes as potential PARACEST contrast agents in MRI or fluorescent molecular probes. In this context amino acid and peptide DOTAMR(4) derivatives are particularly attractive since the amino-acid and/or peptide moiety can show responsive properties dependent on a given stimuli which might translate to changes in water exchange rates of the corresponding Ln(III) complex. Current synthesis of DOTAMR(4) derivatives is typically carried out by reacting haloacetamide intermediates with cyclen. However, this method fails to generate the tetra-substituted products when bulky substituents are present in the haloacetamide and in some cases this intermediate cannot be prepared by conventional acylation procedures limiting the number of DOTAMR(4) compounds available for study. As a solution to these limitations, an improved methodology for the synthesis of DOTAMR(4) by coupling DOTA to an appropriate amine containing reagent (i.e. protected amino-acids with the alpha-amino group free) is presented in this work. Several DOTAMR(4) derivatives which are difficult or impossible to prepare with the traditional methodologies were easily obtained starting with DOTA. A new protocol was derived using this methodology for the solution-phase synthesis of DOTA peptide derivatives. With this methodology, many other DOTAMR(4) peptide and non-peptide derivatives have been prepared in our laboratories with several of these new compounds showing interesting properties for molecular imaging.
新的 DOTA 四酰胺(DOTAMR(4))化合物的合成非常有趣,因为它们可以形成 Ln(III)配合物,作为 MRI 中的 PARACEST 对比剂或荧光分子探针。在这种情况下,氨基酸和肽 DOTAMR(4)衍生物特别有吸引力,因为氨基酸和/或肽部分可以表现出依赖于给定刺激的响应特性,这可能转化为相应 Ln(III)配合物的水交换率的变化。目前,DOTAMR(4)衍生物的合成通常是通过将卤代乙酰胺中间体与环庚三烯反应来进行的。然而,当卤代乙酰胺中存在大体积取代基时,该方法无法生成四取代产物,在某些情况下,该中间体不能通过常规酰化程序来制备,这限制了可用于研究的 DOTAMR(4)化合物的数量。为了解决这些限制,本工作提出了一种通过将 DOTA 与含有适当胺的试剂(即α-氨基未被保护的氨基酸)偶联来合成 DOTAMR(4)的改进方法。与传统方法相比,使用这种方法可以轻松获得几种难以或不可能用传统方法制备的 DOTAMR(4)衍生物。使用这种方法,我们实验室已经制备了许多其他的 DOTAMR(4)肽和非肽衍生物,其中一些新化合物表现出有趣的分子成像特性。